3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Glioblastoma
5
Breast Neoplasms
3
Brain Neoplasms
2
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Non-alcoholic Fatty Liver Disease
1
Multiple Myeloma
1
Intermittent Fasting
1
Fatty Liver
1
Estrogen Receptor-positive Breast Cancer
1
Endometrial Neoplasms
1
Drug Resistant Epilepsy
1
Autism Spectrum Disorder
1
Adenocarcinoma of Lung
1
Interventions
Metformin
21
Inositol
14
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
salicylsalicylic acid
1
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Diet, Ketogenic
×
1 year
×
Clear all
NCT07227363
2026-05-08
(SPARK-Pilot)
Ohio State University
Phase NA
Recruiting
40 enrolled